RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-44

  1. 2,737 Posts.
    lightbulb Created with Sketch. 1317
    A lot of immature investors here who probably should stick to low volatility bluechips and conglomerates, rather than potentially market disruptive start-ups like RAP.

    With all endpoints of the study met, this milestone should be celebrated. Any share price weakness (say back to low 30's) will be temporary and present a buying opportunity IMO. There is way more upside than downside from here and making money will just require the patience to see it through and/or add to your positions.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.